Corbus Pharmaceuticals Holdings (CRBP) Revenue (QoQ) (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) Revenue (QoQ) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -28.73% |
| Jun 30, 2021 | -78.92% |
| Mar 31, 2021 | -62.36% |
| Dec 31, 2020 | 39.85% |
| Sep 30, 2020 | 329.77% |
| Jun 30, 2020 | -83.75% |
| Mar 31, 2020 | 106.17% |
| Dec 31, 2019 | -1,203.18% |
| Sep 30, 2019 | -91.10% |
| Jun 30, 2019 | 1,442.92% |
| Mar 31, 2019 | -2.16% |
| Dec 31, 2018 | 76.67% |
| Sep 30, 2018 | 27.79% |
| Jun 30, 2018 | -10.18% |
| Sep 30, 2017 | 127.40% |
| Jun 30, 2017 | -72.93% |
| Sep 30, 2016 | 87.23% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 8.87% |
| Dec 31, 2015 | 113.72% |